Shiva K.

Shiva K. is an accomplished leader in program and portfolio management within the biotechnology sector, currently serving as the VP, Head of Program Management at Hillstar Bio since May 2025. With prior roles at Alltrna and Orna Therapeutics, where responsibilities included overseeing program strategy, governance, and execution of IND-enabling studies in rare diseases and gene therapies, Shiva has a proven track record in therapeutic areas such as oncology and autoimmune diseases. Extensive experience includes leadership positions at Asklepios BioPharmaceutical, Homology Medicines, Biogen, and Novartis, showcasing expertise in resource planning, collaboration, and strategic sourcing. Shiva holds an MBA from the University of Massachusetts Amherst, a PhD in Molecular Biology from the Center for Cellular and Molecular Biology, and multiple degrees in genetics and biotechnology.